Search

Your search keyword '"Mentz, Robert J"' showing total 1,300 results

Search Constraints

Start Over You searched for: Author "Mentz, Robert J" Remove constraint Author: "Mentz, Robert J" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
1,300 results on '"Mentz, Robert J"'

Search Results

2. The need for increased pragmatism in cardiovascular clinical trials

6. Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials JACC Review Topic of the Week

7. In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection Fraction

8. Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction JACC State-of-the-Art Review

9. Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction

13. Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert Panel

15. Representativeness of a Heart Failure Trial by Race and Sex Results From ASCEND-HF and GWTG-HF

16. Relationship Between Hospital Characteristics and Early Adoption of Angiotensin‐Receptor/Neprilysin Inhibitor Among Eligible Patients Hospitalized for Heart Failure

17. Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes.

19. Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial

20. The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

27. Implications of trial eligibility in patients with heart failure with mildly reduced or preserved ejection fraction.

28. Depressive symptoms are associated with clinical outcomes in heart failure with reduced ejection fraction.

31. Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation

32. Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure

33. Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND‐HF

34. Home-Time After Discharge Among Patients Hospitalized With Heart Failure

35. Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure Insights From ASCEND-HF Trial

37. On‐treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post‐hoc analysis of TRANSFORM‐HF

39. Dietary sodium and fluid intake in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC

43. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

47. Pragmatic Design of Randomized Clinical Trials for Heart Failure: Rationale and Design of the TRANSFORM-HF Trial

50. Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes Findings From the ASCEND-HF Trial

Catalog

Books, media, physical & digital resources